Terry, I think Aratana is definitely making the right moves but they've got a big battle to fight to make Galliprant successful. It's been hard to move off the shelves due to the cost. There are plenty non FDA-approved appetite stimulants in the vet world that have been used successfully since before I was alive that are very cheap. I think they will have to be bought out to stand a chance at surviving but that will also depend on how the partnership and sales go I'm sure. Definitely a company to keep an eye on but I think it'll be at least a year or two until things really start moving
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.